Baker Bros. Advisors LP Orchard Therapeutics PLC Transaction History

Baker Bros. Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.24 - $4.29 $2.67 Million - $5.11 Million	-1,192,003 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.39 - $7.23 $2.01 Million - $3.31 Million	457,572 Added 62.3%	1,192,003 $5.23 Million
Q1 2021 May 17, 2021	BUY	$4.39 - $9.08 $1.76 Million - $3.65 Million	401,929 Added 120.88%	734,431 $5.33 Million
Q4 2020 Feb 16, 2021	SELL	$3.86 - $5.07 $41,302 - $54,249	-10,700 Reduced 3.12%	332,502 $1.44 Million
Q3 2020 Nov 16, 2020	SELL	$4.11 - $6.45 $256,875 - $403,125	-62,500 Reduced 15.41%	343,202 $1.41 Million

Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.63 $3.71 Million - $5.79 Million	280,702 Added 224.56%	405,702 $5.68 Million
Q4 2018 Feb 13, 2019	BUY	$12.4 - $18.7 $1.55 Million - $2.34 Million	125,000 New	125,000 $1.97 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.